Harris Communications Group founder Anita Harris recently covered two sessions at BioPharm America on behalf of the EBD Group, which organized an international partnering conference as part of Boston Biotech Week, 2018.
Here’s a link to the first…
“The biotechnology industry is “awash in cash… we are seeing cash, everywhere.”
Panel members included investment experts Steve Abrams, partner at the Philadelphia law firm Hogan Lovells; Kevin Bitterman, partner at Atlas Venture, in Boston; Alicia Irurzun-Lafitte, principal at M Ventures, the strategic corporate venture capital arm of Merck KGaA, Germany; and Rick Pierce, of Cambridge, MA, founder of FEP Capital Advisors, which provides private equity and investment banking services.
The four addressed questions about who is investing, potential problems, very early stage investment, Chinese influence, and their own investment foci. The panel discussion was held on September 5.
EBD Group is the leading partnering firm for the global biotechnology industry. Since 1993, firms in the life sciences have leveraged EBD Group’s partnering conferences, technology and services to identify opportunities and to develop strategic relationships that drive their business. EBD Group’s partnering events (run in collaboration with leading industry organizations) are:
BIO-Europe®
BIO-Europe Spring®
BioPharm America™
Biotech Showcase™
ChinaBio® Partnering Forum
Bio€quity Europe
–Anita Harris, founder of the Harris Communications Group, is a science writer and communications consultant based in Boston, MA. The Harris Communications Group is a PR, content and digital marketing agency specializing in healthcare, life science, technology, cybersecurity and energy, worldwide.